Cite

HARVARD Citation

    Boundy, K. et al. (2020). Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants. Clinical pharmacology in drug development. 9 (4), pp. 466-475. [Online]. 
  
Back to record